Sight Sciences’ management is scheduled to present on Thursday, February 27, 2025, at 7:15 am PT / 10:15 am ET. Interested parties may access a live and archived webcast of the fireside chat on the ...

In a challenging market environment, Sight Sciences , Inc. (NASDAQ:SGHT) stock has touched a 52-week low, with shares falling to $2.54. With a market capitalization of $130.44 million and an ...

Standalone canaloplasty and trabeculotomy can deliver meaningfully reduced IOP in the long term and require fewer topical therapy agents.

Sight Sciences (NASDAQ:SGHT – Get Free Report) had its target price dropped by analysts at Stifel Nicolaus from $6.00 to $5.00 in a research report issued to clients and investors on Thursday,Benzinga ...

Its Surgical Glaucoma segment's product portfolio features the OMNI Surgical System, a device that facilitates the performance of both canaloplasty and trabeculotomy with a single device and ...

“Good” HDL cholesterol appears to increase risk of glaucoma in people older than 55, researchers reported Feb. 4 in the British Journal of Ophthalmology. Conversely, “bad” LDL cholesterol might be ...

ANN ARBOR, Mich., Feb. 04, 2025 (GLOBE NEWSWIRE) -- ONL Therapeutics, Inc., a clinical-stage biopharmaceutical company developing novel therapies for protecting the vision of patients with retinal ...

Taylyn Washington-Harmon is the associate editor at Health.com. A former social media guru, she's worked for a number of lifestyle and beauty brands and has previously written for SELF and STAT ...

The Amazon Fire TV Omni Mini-LED delivers a dynamic, colorful picture that's the brightest we've seen on a Fire TV yet. It's great for gamers with a wide range of gaming features and handles ...

Pseudoexfoliation glaucoma is linked with an increased risk of heart attack and stroke. Ophthalmologists must be careful to not confuse signs of pseudoexfoliation with pigmentary glaucoma.